# The Potential of HemoScreen for Monitoring Blood Values in Cancer Patients at Home

> **NCT04543734** · — · COMPLETED · sponsor: **Niels Henrik Holländer** · enrollment: 33 (actual)

## Conditions studied

- Cancer

## Interventions

- **DEVICE:** HemoScreen hematology analyzer

## Key facts

- **NCT ID:** NCT04543734
- **Lead sponsor:** Niels Henrik Holländer
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-11
- **Primary completion:** 2022-10-31
- **Final completion:** 2022-10-31
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2022-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04543734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04543734, "The Potential of HemoScreen for Monitoring Blood Values in Cancer Patients at Home". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04543734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*